The Bio Report
Levine Media Group
EN1239 episodes
sciencelifebusinesshealthfitnessmedicine
The Bio Report podcast, hosted by award-winning journalist Daniel Levine, focuses on the intersection of biotechnology with business, science, and policy.
Episodes (1239)
Seeking a Best-in-Class Antibody at Bargain Basement Prices
The Bio Report
Mar 3, 201615:35pending
Pharma Bro, Price Controls, and the Quest to Balance Innovation with Affordabili...
The Bio Report
Feb 25, 201627:03pending
California’s Stem Cell Agency Plots Its Future
The Bio Report
Feb 18, 201623:33pending
ViaCyte Pursues ”Functional Cure” for Type 1 Diabetes
The Bio Report
Feb 11, 201619:34pending
Building a Better Pain Pill
The Bio Report
Feb 4, 201622:05pending
Project GENIE Hopes to Make Precision Medicine a Reality
The Bio Report
Jan 28, 201620:38pending
FDA Wants Industry to Guard Against Cybersecurity Risks of Medical Devices
The Bio Report
Jan 21, 201622:25pending
Pharma’s Leadership Vacuum and Its Price to the Industry
The Bio Report
Jan 14, 201621:58pending
Permanent R&D Tax Credit a Boost to Life Sciences
The Bio Report
Jan 7, 201619:12pending
Biotech in 2015 and the Year Ahead with TheStreet’s Adam Feuerstein
The Bio Report
Dec 31, 201518:44pending
Trends Shaping the New Health Economy in 2016
The Bio Report
Dec 24, 201530:39pending
Declining R&D Productivity Continues to Plague Big Pharma
The Bio Report
Dec 17, 201519:18pending
Searching for Solutions to Rising Specialty Drug Prices
The Bio Report
Dec 10, 201513:37pending
Biohackers Seek a Faster, Cheaper Path to Insulin
The Bio Report
Dec 3, 201519:16pending
A Scorecard to Improve Drugmakers’ Transparency
The Bio Report
Nov 25, 201519:44pending
Forget the Chemistry Set, Mom, I Want a Bioreactor
The Bio Report
Nov 19, 201522:26pending
Ensuring Biological Tools Benefit the Environment
The Bio Report
Nov 13, 201516:57pending
New SEC Rules Open Crowdfunding to the Masses
The Bio Report
Nov 5, 201518:29pending
Harnessing Biology to Address Global Challenges
The Bio Report
Oct 29, 201518:58pending
Immunotherapies ETF Lets Biotech Investors Bet on Emerging Sector
The Bio Report
Oct 22, 201520:44pending
Biotech Investors Turn Their Eyes to Policy Matters
The Bio Report
Oct 16, 201524:18pending
Why the MedTech Industry Should Worry About Future Innovation
The Bio Report
Oct 8, 201523:35pending
Rare Disease Drug Developer Shows Speed of Business Model
The Bio Report
Oct 1, 201518:55pending
Ensuring Value-Based Care Addresses What Matters to Patients
The Bio Report
Sep 24, 201521:04pending
California, Aid-in-Dying, and What We’ve Learned from Oregon
The Bio Report
Sep 17, 201518:12pending
FDA Guidance on Names for Biologics and Biosimilars and its Implications
The Bio Report
Sep 10, 201521:50pending
Understanding the Cost and Value of Cancer Therapies
The Bio Report
Sep 3, 201521:30pending
Jimmy Carter’s Final Wish: Eradicating Guinea Worm
The Bio Report
Aug 27, 201519:37pending
The Quest for a Pink Viagra
The Bio Report
Aug 20, 201520:04pending
Free Speech Ruling May Force FDA to Rethink Off-Label Marketing
The Bio Report
Aug 14, 201520:16pending
Drugmakers Often Late to Report Serious Side Effects
The Bio Report
Aug 6, 201514:12pending
When Hospital Cause, Rather than Cure, Deadly Infections
The Bio Report
Jul 30, 201513:02pending
Rethinking the Value and Price of Drugs
The Bio Report
Jul 23, 201515:44pending
Harnessing Stem Cells to Test Drug Safety
The Bio Report
Jul 16, 201519:32pending
CrowdMed Enlists the Wisdom of Crowds to Solve Medical Mysteries
The Bio Report
Jul 9, 201519:16pending
Biotech’s Record Performance and Looming Threats
The Bio Report
Jul 2, 201519:21pending
What a Decade of Investment Tells Us about the Health of Biotech
The Bio Report
Jun 25, 201514:00pending
What Activist Investors Can Teach Biotech Companies
The Bio Report
Jun 18, 201516:07pending
ALS Fight Carries Muller from Patient to Biotech CEO
The Bio Report
Jun 11, 201517:42pending
Examining the State of Sleep
The Bio Report
Jun 5, 201523:53pending
TheStreet’s Adam Feuerstein Previews ASCO 2015
The Bio Report
May 28, 201513:42pending
Home-Brew Morphine, Dual Use Technology, and the Biologist’s Repsonsibilities
The Bio Report
May 20, 201520:22pending
Reinventing Tech Transfer
The Bio Report
May 14, 201521:04pending
Thinking Narrowly About Antibiotics
The Bio Report
May 7, 201524:22pending
Promise Shown in Different Approach to Alzheimer’s
The Bio Report
Apr 30, 201515:51pending
Innovative Drugs Drive Big Increase in U.S. Spending
The Bio Report
Apr 23, 201519:58pending
Ensuring Digital Health Technologies Benefit Older People
The Bio Report
Apr 16, 201517:47pending
How the Sugar Industry Influenced Research to Protect Its Interests
The Bio Report
Apr 10, 201513:09pending
Examining The White House’s Plan to Combat Drug-Resistant Bacteria
The Bio Report
Apr 3, 201519:34pending
Weighing Adverse Events to Get at a Drug’s Real Costs
The Bio Report
Mar 26, 201516:50pending
......